Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩134,500.00
Day range
₩134,000.00 - ₩135,800.00
Year range
₩86,900.00 - ₩144,100.00
Market cap
10.59T KRW
Avg Volume
368.02K
P/E ratio
33.04
Dividend yield
-
Market news
Times Colonist
7 hours ago
Basic materials stocks weigh on S&P/TSX composite, U.S. markets move higher
0.17%
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 191.73B | 40.35% |
Operating expense | 114.07B | 13.25% |
Net income | 74.14B | 667.88% |
Net profit margin | 38.67 | 446.96% |
Earnings per share | — | — |
EBITDA | 74.11B | 213.77% |
Effective tax rate | -14.90% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 256.16B | -4.25% |
Total assets | 1.03T | 32.89% |
Total liabilities | 340.50B | -16.70% |
Total equity | 689.46B | — |
Shares outstanding | 78.31M | — |
Price to book | 15.66 | — |
Return on assets | 17.68% | — |
Return on capital | 24.55% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 74.14B | 667.88% |
Cash from operations | 65.41B | 191.26% |
Cash from investing | -1.87B | 85.88% |
Cash from financing | -26.65B | -2.54% |
Net change in cash | 33.51B | 277.93% |
Free cash flow | 38.49B | 964.17% |
About
Founded
1993
Website
